trial · primary record
Povetacicept
Primary Membranous Nephropathy
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 176 |
| Primary completion | 2028-12-29 |
| Primary endpoint | Proportion of Participants with Complete Clinical Remission Definition 1 (CR1) |
| Registry ID | NCT07204275 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:40:32.916Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07204275
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Povetacicept · compound